Specialty Pharmaceutical Company dedicated to patients living with chronic conditions

Filing date Description Form Filing Group Filer View

Quarterly report filed by small businesses

10QSB
Quarterly Filings
0000950144-01-506256.pdf 0000950144-01-506256.rtf 0000950144-01-506256.xls View HTML

Annual report filed by small businesses

10KSB
Annual Filings
0000950144-01-506087.pdf 0000950144-01-506087.rtf 0000950144-01-506087.xls View HTML

Notification that form type 10-Q will be submitted late

NT 10-Q
Quarterly Filings
0000950144-01-506090.pdf 0000950144-01-506090.rtf View HTML

Notification that form 10-K will be submitted late

NT 10-K
Annual Filings
0000950144-01-004736.pdf 0000950144-01-004736.rtf View HTML

Amendment to a previously filed 8-K

8-K/A
Current Reports
0000950144-01-001507.pdf 0000950144-01-001507.rtf 0000950144-01-001507.xls View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001103021-00-500008.pdf 0001103021-00-500008.rtf View HTML

Amendment to a previously filed SC 14F1

SC 14F1/A
3,4,5
KNIGHT ROBERT 0001022871-00-500003.pdf 0001022871-00-500003.rtf 0001022871-00-500003.xls View HTML

Quarterly report filed by small businesses

10QSB
Quarterly Filings
0001022871-00-500002.pdf 0001022871-00-500002.rtf 0001022871-00-500002.xls View HTML

Statement regarding change in majority of directors pursuant to Rule 14f-1

SC 14F1
3,4,5
KNIGHT ROBERT 0001022871-00-500001.pdf 0001022871-00-500001.rtf 0001022871-00-500001.xls View HTML

Filing by person(s) reporting owned shares of common stock in a public company >5%

SC 13D
3,4,5
0001103021-00-500006.pdf 0001103021-00-500006.rtf View HTML

Copyright Morningstar

BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic®
Thank you. We will get back to you soon